Change - Announcement of Cessation::Cessation of General Manager

Issuer & Securities

Issuer/ Manager
STAR PHARMACEUTICAL LIMITED
Securities
STAR PHARMACEUTICAL LIMITED - SG1BB3000009 - AYL
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
17-Jul-2018 18:39:19
Status
New
Announcement Sub Title
Cessation of General Manager
Announcement Reference
SG180717OTHRVZNJ
Submitted By (Co./ Ind. Name)
Xu Zhi Bin
Designation
Executive Chairman
Description (Please provide a detailed description of the event in the box below)
Cessation of General Manager of the Company's wholly-owned subsidiary, Hainan Star Pharmaceutical Co., Ltd.

Additional Details

Name Of Person
Li Qing Ming
Age
44
Is effective date of cessation known?
Yes
If yes, please provide the date
17/07/2018
Detailed Reason (s) for cessation
Due to personal health reason.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
01/03/2016
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
1
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
1
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
General Manager of Hainan Star Pharmaceutical Co., Ltd.
Role and responsibilities
Executive. Responsible for overseeing the planning and management of the quality and production operations, business development strategies as well as managing the new drug's research and development.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Nil
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
Nil
Present
Nil